In the Spotlight - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

In the Spotlight
New product reviews from March 2011.

Pharmaceutical Technology
Volume 35, Issue 3, pp. 24

Editors' Picks of Pharmaceutical Science & Technology Innovations

Automation has become increasingly important to the pharmaceutical industry, partly because it can enhance product quality and reduce the occurrence of deviations. Many vendors provide devices intended to control manufacturing and quality-assurance operations, and drugmakers have come to rely on these innovations. This month's products are intended for various process-control applications. The new model of Stratophase's data-monitoring unit helps indicate process status. Two of Shimadzu's gas-chromatography instruments now can be controlled through Waters's Empower 2 software. A pressure logger is the latest addition to Mesa Laboratories's series of process-validation systems.

Data-monitoring unit offers process control


Benchtop data-monitoring unit Stratophase www.stratophase.com
The new model of Stratophase's benchtop data-monitoring unit lets personnel track eight independent SpectroSens probes simultaneously and has a smaller footprint than the previous model did. The new machine includes a built-in touch-screen monitor that eliminates the need for a separate monitor, keyboard, or mouse. Users can implement the benchtop data-monitoring unit as stand-alone process-monitoring and data-analysis system, or network it with other process-control equipment as part of a process-management system. The probes' optical microchip sensor technology offers measurements that can indicate process status and product quality.

Stratophase's data-monitoring unit uses temperature-compensated refractive index as a measurement of concentration, thus providing information that can be used to control a process directly. Personnel can use the data gathered by Stratophase's system to profile the process and compare real-time data to a historical process model.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here